Key Points
- Director Christopher Brown sold 2,200 shares of 908 Devices at an average price of $9.02, for a total of $19,844, in a pre-arranged Rule 10b5-1 transaction.
- After the sale, Brown still held 843,359 shares valued at about $7.6 million, and the transaction reduced his position by just 0.26%.
- 908 Devices stock was trading down about 4.2%, while analysts currently show a mixed view with an average Hold rating and a $12.00 target price.
908 Devices Inc. (NASDAQ:MASS - Get Free Report) Director Christopher Brown sold 2,200 shares of the firm's stock in a transaction dated Thursday, July 2nd. The stock was sold at an average price of $9.02, for a total value of $19,844.00. Following the transaction, the director owned 843,359 shares in the company, valued at approximately $7,607,098.18. This trade represents a 0.26% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
908 Devices Trading Down 4.2%
908 Devices stock opened at $8.07 on Wednesday. The firm has a market capitalization of $305.13 million, a P/E ratio of -8.07 and a beta of 0.63. The business has a 50-day moving average of $8.05 and a 200-day moving average of $6.92. 908 Devices Inc. has a 1 year low of $5.03 and a 1 year high of $9.34.
Analyst Ratings Changes
Several brokerages have commented on MASS. Weiss Ratings downgraded shares of 908 Devices from a "hold (c-)" rating to a "sell (d-)" rating in a research note on Monday, May 11th. Wall Street Zen raised shares of 908 Devices from a "hold" rating to a "buy" rating in a research report on Saturday, June 27th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat.com, 908 Devices has an average rating of "Hold" and an average target price of $12.00.
View Our Latest Analysis on MASS
Institutional Investors Weigh In On 908 Devices
Large investors have recently modified their holdings of the business. Raymond James Financial Inc. acquired a new stake in shares of 908 Devices during the second quarter worth about $48,000. Daiwa Securities Group Inc. acquired a new position in shares of 908 Devices in the 2nd quarter valued at approximately $61,000. Intelligence Driven Advisers LLC bought a new stake in 908 Devices during the 1st quarter worth approximately $61,000. Russell Investments Group Ltd. bought a new stake in 908 Devices during the 3rd quarter worth approximately $93,000. Finally, The Manufacturers Life Insurance Company acquired a new stake in 908 Devices during the 2nd quarter worth approximately $77,000. 88.06% of the stock is currently owned by institutional investors.
908 Devices Company Profile
(
Get Free Report)
908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company's core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.
Key products in 908 Devices' portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
